Why Danaher Stock Soared in April

Shares in life sciences and diagnostics company Danaher (NYSE: DHR) rose 12.8% in April, according to data provided by S&P Global Market Intelligence. An excellent set of first-quarter earnings drove the stock higher during the month. The company easily beat market expectations for the quarter and raised its full-year guidance. 

Danaher is one of the big winners of the COVID-19 pandemic, benefiting not only from a surge in revenue from sales of its COVID-19 diagnostic tests but also the company's life sciences tools, which are widely used by customers working on both vaccines and therapies.

Image source: Getty Images.

Continue reading

Source Fool.com